Aptose Biosciences Inc.
APTOF
$1.71
$0.031.91%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -389.53% | 26.32% | 2.88% | 42.50% | 86.74% |
| Total Depreciation and Amortization | -5.45% | 15.63% | 0.00% | -9.17% | -350.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 448.02% | 13,500.00% | -27.21% | -43.03% | -146.33% |
| Change in Net Operating Assets | 123.74% | 24.14% | -27.27% | 170.40% | -384.97% |
| Cash from Operations | 27.53% | 28.58% | -2.86% | 76.24% | 12.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -22.50% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -93.00% | 687.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 1,460.00% |
| Cash from Financing | 21.97% | -22.56% | -47.41% | -93.00% | 696.84% |
| Foreign Exchange rate Adjustments | -- | -- | -100.00% | 100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 295.94% | 192.12% | -450.10% | -3.04% | 80.60% |